Outcomes and Treatment of Chronic Methicillin-ResistantStaphylococcus aureusDiffers by Staphylococcal Cassette Chromosomemec(SCCmec) Type in Children With Cystic Fibrosis | Zendy

Sonya L. Heltshe | Zendy; Lisa Saiman | Zendy; Elena B. Popowitch | Zendy; Melissa B. Miller | Zendy; Margaret Kloster | Zendy; Valeria Thompson | Zendy; Thomas Ferkol | Zendy; Wynton Hoover | Zendy; Michael S. Schechter | Zendy; Marianne S. Muhlebach | Zendy

Open Access

Outcomes and Treatment of Chronic Methicillin-ResistantStaphylococcus aureusDiffers by Staphylococcal Cassette Chromosomemec(SCCmec) Type in Children With Cystic Fibrosis

Author(s) -

Sonya L. Heltshe,

Lisa Saiman,

Elena B. Popowitch,

Melissa B. Miller,

Margaret Kloster,

Valeria Thompson,

Thomas Ferkol,

Wynton Hoover,

Michael S. Schechter,

Marianne S. Muhlebach

Publication year - 2014

Publication title -

journal of the pediatric infectious diseases society

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.269

H-Index - 31

eISSN - 2048-7207

pISSN - 2048-7193

DOI - 10.1093/jpids/piu048

Subject(s) - sccmec , medicine , staphylococcus aureus , microbiology and biotechnology , antibiotics , methicillin resistant staphylococcus aureus , biology , bacteria , genetics

Methicillin-resistant Staphylococcus aureus (MRSA) infects ∼25% of patients with cystic fibrosis (CF) in the United States. We hypothesized that health-related outcomes differed between healthcare-associated (staphylococcal cassette chromosome mec [SCCmec] II) vs community-associated (SCCmec IV) MRSA strains in patients chronically infected with CF.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research